Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer
Authors:
- 17 August 2022
- journal article
- research article
- Published by Elsevier in Cell Systems
- Vol. 13 (9) , 690-710.e17
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- International Association for the Study of Lung Cancer (2R01 DK106228, P30-CA086485, P50CA236733, R01DK103831, R50CA24378 3, U01CA215798, U01CA224276-01, U54CA217450-01, UG1CA233259)
- American Society of Clinical Oncology
- Vanderbilt University
- Pfizer
- Novartis
- National Institutes of Health
- National Cancer Institute (U54CA217450)
- Conquer Cancer Foundation
- National Comprehensive Cancer Network
- G1 Therapeutics
- National Science Foundation (1R01CA251147-01A1, 2K12CA090625-17, 5U01CA231844-03, 5U24CA213274-04, DGE-1445197)
This publication has 120 references indexed in Scilit:
- The ConsensusPathDB interaction database: 2013 updateNucleic Acids Research, 2012
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesisProceedings of the National Academy of Sciences, 2012
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 2012
- Molecular signatures database (MSigDB) 3.0Bioinformatics, 2011
- Cellular Heterogeneity: Do Differences Make a Difference?Cell, 2010
- GOSemSim: an R package for measuring semantic similarity among GO terms and gene productsBioinformatics, 2010
- The role of hypoxia and neurogenic genes (Mash-1 and Prox-1) in the developmental programming and maturation of pulmonary neuroendocrine cells in fetal mouse lungLaboratory Investigation, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutantBritish Journal of Cancer, 2008